DRG Epidemiology's coverage of acute ischemic stroke (AIS) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom and Japan). We report both the incidence and prevalence of AIS for each country, as well as annualized case counts projected to the national population.
DRG Epidemiology's AIS forecast will answer the following questions:
- How will changes in the levels of exposure to known risk or protective factors affect the number of events of AIS per year?
- Of all AIS events, how many in each country across the major mature pharmaceutical markets have been formally diagnosed?
- Of all AIS events, how many in each country across the developed world are drug-treated?
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of AIS over the forecast period?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In addition to the total number of cases for each forecast year, DRG Epidemiology also provides at least ten years of forecast data for the following AIS subpopulations:
- Total events by diagnosis status
- Diagnosed events by time to hospital presentation
- Diagnosed events by drug-treatment status
- Twelve-month diagnosed prevalent cases
- Life-time diagnosed prevalent cases
Note: coverage may vary by country and region.
- Ischemic Stroke - Epidemiology - Mature Markets Data
- Key Findings
- Event Rate of Acute Ischemic Stroke per 1,000 Among People of All Ages in 2018 and 2028
- Relative Sizes of the Contributing Factors to the Trend in Events of Acute Ischemic Stroke over the Next 10 Years
- Analysis of Diagnosed Events of Acute Ischemic Stroke Across the Countries Under Study in 2016 by Time Between Onset and Presentation to Hospital
- Analysis of the Events of Acute Ischemic Stroke in 2016 by Diagnosed and Drug-Treated Status
- Number of Events of Acute Ischemic Stroke Avoided Over the Period from 2016-2026 Across the Countries Under Study
- Epidemiology Data
- Total Acute Ischemic Stroke Events
- Total Lifetime Prevalence
- 12-month Diagnosed Prevalent Cases
- Time Between Stroke Onset and Presentation to a Hospital
- Diagnosed Prevalent Cases
- Drug-Treated Prevalent Cases
- Reference Materials
- Literature Review
- Studies Included in the Analysis of Acute Ischemic Stroke
- Studies Excluded from the Analysis of Acute Ischemic Stroke
- Risk/Protective Factors
- Risk/Protective Factors for Acute Ischemic Stroke
- Literature Review
Author(s): Sunali D. Goonesekera, SM
Sunali Goonesekera is an Associate Epidemiologist at Decision Resources Group.
Sunali holds a Master’s degree in Epidemiology from the Harvard School of Public Health and a B.A. in Biology (Honors) from Dartmouth College. Prior to joining Decision Resources Group, Sunali conducted epidemiological research and lead authored two manuscripts on racial/ethnic disparities in metabolic diseases at the New England Research Institutes. She has contributed to multiple publications in peer-reviewed journals in epidemiology and in the biological sciences.